pyrazolanthrone has been researched along with Disease, Pulmonary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, WJ; Chen, LW; Hsu, CM; Wang, JS | 1 |
| Enkhbaatar, P; Traber, D; Traber, L | 1 |
| Farivar, AS; McCourtie, AS; Merry, HE; Mulligan, MS; Wolf, PS | 1 |
3 other study(ies) available for pyrazolanthrone and Disease, Pulmonary
| Article | Year |
|---|---|
Interleukin-1 mediates thermal injury-induced lung damage through C-Jun NH2-terminal kinase signaling.
Topics: Animals; Anthracenes; Burns; Chemokine CXCL2; Intercellular Adhesion Molecule-1; Interleukin-1; JNK Mitogen-Activated Protein Kinases; Lung; Lung Diseases; Mice; Mice, Knockout; Monokines; Neutrophils; Nitric Oxide Synthase Type II; Peroxidase; Peroxynitrous Acid; Receptors, Interleukin-1 Type I; Receptors, Interleukin-8B; Receptors, Tumor Necrosis Factor, Type I; RNA, Messenger; Signal Transduction; Vascular Cell Adhesion Molecule-1 | 2007 |
Interleukin-1 in thermal injury: what is next?
Topics: Animals; Anthracenes; Burns; Interleukin-1; JNK Mitogen-Activated Protein Kinases; Lung Diseases; Mice; Mice, Knockout; Receptors, Interleukin-1 Type I; Signal Transduction | 2007 |
Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury.
Topics: Animals; Anthracenes; Blotting, Western; Bronchoalveolar Lavage Fluid; Butadienes; Disease Models, Animal; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Immunohistochemistry; Inflammation Mediators; Lung Diseases; Male; Mitogen-Activated Protein Kinases; Nitriles; Oxidative Stress; Peroxidase; Phosphorylation; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Reperfusion Injury; Sensitivity and Specificity | 2008 |